Cargando…
Long‐acting growth hormone in 2022
After the isolation of pituitary growth hormone (GH) in 1957, this form of GH, always in limited supply, was the only drug available for the treatment of GH deficiency. In 1985, recombinant GH became available, and the modalities of GH therapies changed dramatically as the supply was unlimited. New...
Autores principales: | Steiner, Margaret, Frank, Jacklyn, Saenger, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030690/ https://www.ncbi.nlm.nih.gov/pubmed/36967745 http://dx.doi.org/10.1002/ped4.12358 |
Ejemplares similares
-
Long acting growth hormone (LAGH), an update
por: Grillo, Margaret Steiner, et al.
Publicado: (2023) -
Current Status of Biosimilar Growth Hormone
por: Saenger, Paul
Publicado: (2009) -
Ten years of biosimilar recombinant human growth hormone in Europe
por: Saenger, Paul
Publicado: (2017) -
Growth Hormone Research Society perspective on the development of
long-acting growth hormone preparations
por: Christiansen, Jens Sandahl, et al.
Publicado: (2016) -
Perspectives on long-acting growth hormone therapy in children and adults
por: Lal, Rayhan A., et al.
Publicado: (2019)